TY - JOUR
T1 - What is the optimal duration of oral misoprostol treatment for cervical ripening?
AU - Drakopoulos, Panagiotis
AU - Duyck, Céline
AU - Gayet-Ageron, Angèle
AU - Fernandez, Sonia
AU - Irion, Olivier
AU - Martinez de Tejada, Begoña
PY - 2017/6
Y1 - 2017/6
N2 - OBJECTIVES: To evaluate the number of misoprostol tablets needed to obtain a Bishop score (BS) ≥ 6 or a significant cervical change (≥2 points in BS) during cervical ripening.METHODS: Retrospective study of women with term singleton pregnancies and a BS < 6 taking oral misoprostol (20 μg first 2 doses followed by 40 μg every 2 h) for cervical ripening.RESULTS: We included 400 women, 72% nulliparous, mean age of 31.3 ± 5.9 years and 70% with a baseline BS ≤ 2. During cervical ripening, 61 (15.3%) achieved a BS ≥ 6 and 205 (51.3%) a significant change in BS. The incremental risk to achieve a BS ≥ 6 after 4 tablets was low (+3.25%) with an incremental probability of +12.75% for painful uterine contractions and +0.5% for abnormal fetal tracing (AFT). The incremental probability to achieve a significant change in BS after 7 tablets was low (+2.0%). 24.3% women delivered by cesarean section which likelihood significantly increased with maternal age <35 years, BMI ≥ 30, nulliparity, AFT, and baseline BS ≤ 2.CONCLUSIONS: The marginal benefit of giving more than 7 misoprostol tablets (14 h) during cervical ripening is very low.
AB - OBJECTIVES: To evaluate the number of misoprostol tablets needed to obtain a Bishop score (BS) ≥ 6 or a significant cervical change (≥2 points in BS) during cervical ripening.METHODS: Retrospective study of women with term singleton pregnancies and a BS < 6 taking oral misoprostol (20 μg first 2 doses followed by 40 μg every 2 h) for cervical ripening.RESULTS: We included 400 women, 72% nulliparous, mean age of 31.3 ± 5.9 years and 70% with a baseline BS ≤ 2. During cervical ripening, 61 (15.3%) achieved a BS ≥ 6 and 205 (51.3%) a significant change in BS. The incremental risk to achieve a BS ≥ 6 after 4 tablets was low (+3.25%) with an incremental probability of +12.75% for painful uterine contractions and +0.5% for abnormal fetal tracing (AFT). The incremental probability to achieve a significant change in BS after 7 tablets was low (+2.0%). 24.3% women delivered by cesarean section which likelihood significantly increased with maternal age <35 years, BMI ≥ 30, nulliparity, AFT, and baseline BS ≤ 2.CONCLUSIONS: The marginal benefit of giving more than 7 misoprostol tablets (14 h) during cervical ripening is very low.
KW - Administration, Oral
KW - Adult
KW - Cervical Ripening/drug effects
KW - Delivery, Obstetric/statistics & numerical data
KW - Drug Administration Schedule
KW - Female
KW - Humans
KW - Labor, Induced/methods
KW - Misoprostol/administration & dosage
KW - Oxytocics/administration & dosage
KW - Pregnancy
KW - Proportional Hazards Models
KW - Retrospective Studies
KW - Time Factors
U2 - 10.1080/14767058.2016.1220520
DO - 10.1080/14767058.2016.1220520
M3 - Article
C2 - 27493019
SN - 1476-7058
VL - 30
SP - 1494
EP - 1499
JO - Journal of Maternal-Fetal and Neonatal Medicine
JF - Journal of Maternal-Fetal and Neonatal Medicine
IS - 12
ER -